ABA Chemicals to Invest in CDMO/CRO Services Firm

MT Newswires Live

02-10

ABA Chemicals (SHE:300261) plans to invest in Gansu Haotian Technology by acquiring existing shares and possibly subscribing to newly registered capital, according to a Monday filing with the Shenzhen Stock Exchange.

The move aims to enhance ABA Chemicals's pharmaceutical business by leveraging Haotian's CDMO and CRO expertise.

While discussions are ongoing, no formal agreement has been signed, and the investment structure is yet to be finalized. Further disclosures will be made as the deal progresses.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2510335178"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2510335178\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2510335178?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-10 16:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2510335178","market":"sg","top_or_hot":-1,"title":"ABA Chemicals to Invest in CDMO/CRO Services Firm","media":"MT Newswires Live","content":"<html><body><p> ABA Chemicals (SHE:300261) plans to invest in Gansu Haotian Technology by acquiring existing shares and possibly subscribing to newly registered capital, according to a Monday filing with the Shenzhen Stock Exchange.</p><p>The move aims to enhance ABA Chemicals's pharmaceutical business by leveraging Haotian's CDMO and CRO expertise.</p><p>While discussions are ongoing, no formal agreement has been signed, and the investment structure is yet to be finalized. Further disclosures will be made as the deal progresses.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ABA Chemicals to Invest in CDMO/CRO Services Firm</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nABA Chemicals to Invest in CDMO/CRO Services Firm\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-02-10 16:38</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> ABA Chemicals (SHE:300261) plans to invest in Gansu Haotian Technology by acquiring existing shares and possibly subscribing to newly registered capital, according to a Monday filing with the Shenzhen Stock Exchange.</p><p>The move aims to enhance ABA Chemicals's pharmaceutical business by leveraging Haotian's CDMO and CRO expertise.</p><p>While discussions are ongoing, no formal agreement has been signed, and the investment structure is yet to be finalized. Further disclosures will be made as the deal progresses.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0229","symbol_name":"化學制品","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2510335178","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2510335178","pubTimestamp":1739176709,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"ABA Chemicals  plans to invest in Gansu Haotian Technology by acquiring existing shares and possibly subscribing to newly registered capital, according to a Monday filing with the Shenzhen Stock Exchange.The move aims to enhance ABA Chemicals's pharmaceutical business by leveraging Haotian's CDMO and CRO expertise.While discussions are ongoing, no formal agreement has been signed, and the investment structure is yet to be finalized. Further disclosures will be made as the deal progresses.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300261":"雅本化学","BK0229":"化学制品","CDMO":"Avid Bioservices, Inc.","BK4139":"生物科技","BK0174":"增持","BK0028":"国家队"},"translate_title":"ABA Chemicals将投资CDMO/CRO服务公司","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300261":0.9,"CDMO":1},"content_text":"ABA Chemicals (SHE:300261) plans to invest in Gansu Haotian Technology by acquiring existing shares and possibly subscribing to newly registered capital, according to a Monday filing with the Shenzhen Stock Exchange.The move aims to enhance ABA Chemicals's pharmaceutical business by leveraging Haotian's CDMO and CRO expertise.While discussions are ongoing, no formal agreement has been signed, and the investment structure is yet to be finalized. Further disclosures will be made as the deal progresses.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}